SMTL ID : 7v1u.1

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZJ12

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.82 Å

Oligo State

monomer

Ligands

1 x 5E3: ~{N}-(3-ethyl-6-methoxy-1,2-benzoxazol-5-yl)-2-methoxy-benzenesulfonamide(Non-covalent)

5E3.1: 11 residues within 4Å: Chain A: W.54, P.55, F.56, V.60, L.65, L.67, Y.112, N.113, D.118, I.119, M.122 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.54, A:F.56, A:V.60, A:L.65, A:D.118, A:I.119, A:I.119 Hydrogen bonds: A:N.113 Water bridges: A:L.65

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 1 residues within 4Å: Chain A: T.139 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, M.F. et al., Design, synthesis and pharmacological characterization of N-(3-ethylbenzo[d]isoxazol-5-yl) sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia. Acta Pharmacol.Sin. (2022)

Release Date

2022-08-10

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence